Newborn screening in fabry disease

What can be achieved with early diagnosis?

Olaf A. Bodamer

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
JournalClinical Therapeutics
Volume30
Issue numberSUPPL. 2
DOIs
StatePublished - Apr 4 2008

Fingerprint

Lysosomal Storage Diseases
Fabry Disease
Neonatal Screening
Tandem Mass Spectrometry
Early Diagnosis
Biomarkers
Newborn Infant

ASJC Scopus subject areas

  • Pharmacology

Cite this

Newborn screening in fabry disease : What can be achieved with early diagnosis? / Bodamer, Olaf A.

In: Clinical Therapeutics, Vol. 30, No. SUPPL. 2, 04.04.2008.

Research output: Contribution to journalArticle

@article{0c1c67c2672b4d0fbf488ad45b03fae2,
title = "Newborn screening in fabry disease: What can be achieved with early diagnosis?",
author = "Bodamer, {Olaf A.}",
year = "2008",
month = "4",
day = "4",
doi = "10.1016/S0149-2918(08)80035-5",
language = "English",
volume = "30",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Newborn screening in fabry disease

T2 - What can be achieved with early diagnosis?

AU - Bodamer, Olaf A.

PY - 2008/4/4

Y1 - 2008/4/4

UR - http://www.scopus.com/inward/record.url?scp=41449085196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41449085196&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(08)80035-5

DO - 10.1016/S0149-2918(08)80035-5

M3 - Article

VL - 30

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - SUPPL. 2

ER -